Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction.
暂无分享,去创建一个
S. H. Chen | S H Chen | J E Oakes | R N Lausch | J. Oakes | R. Lausch | S. Chen
[1] S. Mittnacht,et al. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. , 1988, Virology.
[2] T. K. Hughes,et al. Synergy of antiviral actions of TNF and IFN-γ: Evidence for a major role of TNF-induced IFN-β , 1988 .
[3] J. Oakes,et al. Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. , 1991, Current eye research.
[4] R. Weiss. Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication. , 1989, American journal of veterinary research.
[5] V. Raju,et al. Differences in natural and recombinant interferon for herpes keratitis in two animal models. , 1984, Investigative ophthalmology & visual science.
[6] C. Dieffenbach,et al. Beta interferon subtype 1 induction by tumor necrosis factor , 1989, Molecular and cellular biology.
[7] B. Aggarwal,et al. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.
[8] L. Smith,et al. Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. , 1989, Current eye research.
[9] T. Tumpey,et al. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. , 1991, The Journal of general virology.
[10] L. Old,et al. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Brinton,et al. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. , 1990, Journal of interferon research.
[12] D. Wallach,et al. Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. , 1985, Cellular immunology.
[13] B. Beutler,et al. The biology of cachectin/TNF--a primary mediator of the host response. , 1989, Annual review of immunology.
[14] D. Falke,et al. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. , 1991, The Journal of general virology.
[15] B. Aggarwal,et al. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin , 1984, The Journal of experimental medicine.
[16] Marian C. Horzinek,et al. Tumour necrosis factor α, interferon γ and interferon β exert antiviral activity in nervous tissue cells , 1991 .
[17] J. Oakes,et al. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon , 1990, Journal of virology.
[18] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[19] Koff Wc,et al. Human tumor necrosis factor-alpha kills herpesvirus-infected but not normal cells. , 1986 .
[20] S. Mittnacht,et al. Different effects of IFNγ and IFNα/β on “immediate early” gene expression of HSV-1 , 1990 .
[21] C. Cubitt,et al. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. , 1993, Investigative ophthalmology & visual science.
[22] G. Wong,et al. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.
[23] P. Asbell,et al. The response of Langerhans cells in the cornea to herpetic keratitis. , 1987, Current eye research.
[24] H. Staats,et al. Effective antibody therapy in herpes simplex virus ocular infection. Characterization of recipient immune response. , 1990, Intervirology.
[25] S. Mittnacht,et al. Antiviral effects of recombinant tumour necrosis factor in vitro , 1986, Nature.
[26] Luis Carrasco,et al. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. , 1991, Virology.
[27] C. Chan,et al. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. , 1988, Investigative ophthalmology & visual science.
[28] D. Goeddel,et al. Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.
[29] S. Baron,et al. Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. , 1987, Microbial pathogenesis.
[30] G. Hensel,et al. Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. , 1990, The Journal of biological chemistry.
[31] T. Taniguchi,et al. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Ito,et al. Antiviral effects of recombinant human tumor necrosis factor. , 1987, Lymphokine research.
[33] B. Williams,et al. Transcriptional regulation of interferon-stimulated genes. , 1991, European journal of biochemistry.
[34] H. Kamiya,et al. Effects of tumor necrosis factor alpha on replication of varicella-zoster virus. , 1991, Antiviral research.
[35] J. Larrick,et al. Journal of Leukocyte Biology 45:429-433 (1989) Activated Langerhans Cells Release Tumor Necrosis Factor , 2022 .
[36] J. Vilček,et al. Production of High-Titered Interferon in Cultures of Human Diploid Cells , 1972, Antimicrobial Agents and Chemotherapy.